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Abstract
We have cloned the first glucose transporter CaHGT1 (Candida albicans high-affinity glucose transporter) of a pathogenic yeast, Candida
albicans. The DNA sequence (GenBank accession number Y16834) analysis revealed an ORF encoding a novel protein of 545 amino acids
with a predicted molecular mass of 60.67 kDa. The putative protein with 12 transmembrane domains has 51% identity with Kluyveromyces
lactis high-affinity glucose transporter, HGT1. The protein signatures which are conserved and distinctive of the sugar transporters
belonging to the major facilitator superfamily (MFS) were also found in CaHgt1p. When heterologously expressed, the ORF functionally
complemented a mutant strain of Saccharomyces cerevisiae RE700A which was deleted in seven hexose transporter genes and thus was
unable to grow or transport glucose. The expression of CaHGT1 in C. albicans showed a transcript of 1.6 kb which was enhanced in
response to the human steroid hormone progesterone. Interestingly, the transcript levels were also enhanced in the presence of drugs, e.g.
cycloheximide, chloramphenicol and benomyl. The results suggest that CaHGT1, which encodes a MFS protein, could be linked to the drug
resistance phenomenon in C. albicans. ß 2000 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Candida albicans is an opportunistic, infectious patho-
genic yeast, which particularly infects immuno-compro-
mised patients such as AIDS and organ transplant pa-
tients [1,2]. There is considerable interest to understand
the mechanisms of regulation of growth and morphogen-
esis of this yeast, which is a¡ected by several factors in-
cluding carbon sources [2,3]. There is evidence to suggest
that C. albicans accumulates a number of sugars, such as
L-sorbose, D-xylose, D- and L-arabinose, against concentra-
tion gradients [4,3]. However, unlike other yeasts, work on
sugar transport and transporters of C. albicans is still at an
incipient stage and an in-depth investigation is required to
gain insight into the mechanisms underlying transport of
sugars.
The emergence of antifungal resistance in C. albicans
has become a major threat to the usefulness of chemo-
therapy in treating the infection. To date several genes
have been identi¢ed whose expression is linked to azole
resistance [5^7]. How these genes are regulated is being
vigorously pursued, and transcription factors like FCR
(£uconazole resistance) 1,2,3 and CAP1 (C. albicans AP-
1) regulating MDR genes of C. albicans have been identi-
¢ed [8]. The well studied yeast, Saccharomyces cerevisiae,
whose genome is completely sequenced, revealed several
genes involved in pleiotropic drug resistance (PDR) along
with several transcription factors which regulate their ex-
pression [9,10]. Interestingly, two putative sugar transport-
ers, i.e. HXT9 and HXT11, are regulated by transcription
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factors, PDR1 and PDR3, which are known to regulate
PDR genes of S. cerevisiae [11]. The facilitative glucose
transporter GLUT1 has also been shown to be involved
in the development of drug resistance in mammalian cells
[12].
This paper describes the molecular cloning of the ¢rst
glucose transporter gene, CaHGT1 (Candida albicans high-
a⁄nity glucose transporter) of C. albicans. Using heterol-
ogous expression in S. cerevisiae mutant strain RE700A,
the functionality of CaHGT1 is demonstrated. It encodes a
high-a⁄nity glucose transporter. In addition, an enhance-
ment of CaHGT1 transcript is shown in response to the
human steroid hormone progesterone and drugs. The re-
sults suggest that CaHGT1, which encodes a major facil-
itator superfamily (MFS) protein, could be linked to the
drug resistance phenomenon in C. albicans.
2. Materials and methods
2.1. Strains and media
C. albicans ATCC 10261 was grown on YEPD medium
(2% Bacto peptone, 1% yeast extract and 2% D-glucose).
The glucose transport-de¢cient mutant of S. cerevisiae
RE700A (MATa ura3-52 hxt1v : :HIS3 : :vhxt4 hxt5 : :
LEU2 hxt2v : :HIS3 hxt3v : :LEU2 : :vhxt6 hxt7 : :HIS3)
[13] was maintained on YEP medium containing 2% mal-
tose. RE700A was transformed with the expression vector
pYEX-BX containing CaHGT1 downstream of the CUP1
promoter. The transformant was selected on minimal
YNB medium consisting of 0.67% yeast nitrogen base
and 2% carbon source (maltose or D-glucose) supple-
mented with appropriate amino acids without uracil. Plas-
mid pYEX-BX was induced by adding 0.5 mM copper
sulfate. Transformation of S. cerevisiae RE700A and plas-
mid recovery from the transformants was carried out as
described elsewhere [14].
2.2. PCR and DIG labeling
CaHGT1 was cloned by amplifying C. albicans genomic
DNA through PCR using primers: forward primer: 5P-
ATGATGTTAGGTTTTGATATTTCTTCAATG-3P, re-
verse primer: 5P-CCCAATAATCAATTGAGCACGATT-
TTGAAC-3P, designed from an unpublished partial se-
quence of the putative C. albicans sugar transporter
(http://www.alces.med.umn.edu). The PCR product
(260 bp) was ligated as a blunt-end fragment (Sure Clone
Ligation Kit, Pharmacia, Freiburg, Germany) to SmaI-
digested pUC18 (Pharmacia). This was sequenced and
used as a probe for Southern hybridisation. All the probes
used in the Southern blotting were labeled with digoxige-
nin-11-dUTP (DIG) using the random primer method
with the DIG DNA Labeling kit from Boehringer Mann-
heim.
2.3. Subcloning and sequencing
Genomic DNA HindIII fragments were ligated to Hin-
dIII-digested pUC18 and HincII fragments from the fos-
mids were ligated to SmaI-digested pUC18. The constructs
were used to transform Escherichia coli XL1 Blue cells.
Plasmids recovered from the resulting transformed colo-
nies were screened by the method of Southern hybridisa-
tion. Subclones were made using the restriction enzyme
sites delineated by restriction mapping. These positive sub-
clones were sequenced by the dideoxy chain termination
method using double-stranded plasmid DNA as template
[15].
A BamHI site was placed upstream of the putative
CaHGT1 ATG start codon (5P-ATAATCTCAAGGATC-
CATGTCGTCCAA) and a PstI site was placed down-
stream of the stop codon UAA (3P-CCTAAATGGAATT-
TAGCTGCAGCTTCAATTCTTCA) by PCR ampli¢ca-
tion of the clone pAV-CaHGT1 containing the full ORF
of CaHGT1. The resulting PCR product was double-
digested with BamHI and PstI and then ligated to the
yeast expression vector pYEX-BX double-digested with
BamHI and PstI downstream of the CUP1 promoter.
2.4. RNA extraction and Northern blotting
Total RNA isolation from C. albicans cells and North-
ern analyses were as described earlier [5].
2.5. Glucose uptake and accumulation assays
The cells were grown to mid-exponential phase (15^16
h), harvested, washed with distilled water and incubated at
30‡C for 2 h in fresh medium containing 0.1% D-glucose.
Consumption of D-glucose from the medium was assayed
enzymatically as described by Bergmeyer [16].
2.6. Nucleotide sequence accession number
The CaHGT1 nucleotide sequence has been assigned
GenBank accession number Y16834.
3. Results and discussion
3.1. Isolation of the C. albicans CaHGT1 Gene
A partial unpublished DNA sequence (http://www.al-
ces.med.umn.edu) of a putative glucose transporter
HGT1 of C. albicans was used to design two oligonucleo-
tide primers. Under conditions of high stringency, these
primers were used for PCR ampli¢cation with C. albicans
ATCC 10261 genomic DNA. The puri¢ed PCR product of
expected size (260 bp) was cloned into the pUC18 vector.
Two positive clones were sequenced and found to be iden-
tical, both displayed 85% sequence identity with the high-
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a⁄nity glucose transporter HGT1 of Kluyveromyces lactis.
The insert from one of these clones was used as a probe
for genomic DNA Southern hybridisation. A V3-kb pos-
itive band was cloned in pUC18 (pAV1) and used for
further characterisation. DNA sequence analysis of
pAV1 revealed an incomplete ORF in the cloned 3-kb
insert with homology to HGT1 of K. lactis and hexose
transporter genes (HXTs) of S. cerevisiae [17,18] and was
found to be localised on chromosome I. In order to clone
the complete ORF, the corresponding fosmid library of
C. albicans [19], containing chromosome I fragments,
was screened using the 1-kb EcoRI-HindIII subfrag-
ment of pAV1 (pAV4, Fig. 1A) as a probe. Southern
analysis gave two positive bands of 4.2 kb and 2 kb
from fosmids 11D6 and 18B4. The 4.2-kb HincII fragment
was further subcloned into pUC18 at the SmaI site
(pAV2) (Fig. 1A). DNA sequence analysis of pAV2 re-
vealed that pAV1 and pAV2 had 100% identity in the
overlapping region (Fig. 1A). In order to reconstruct the
full ORF, the EcoRV-KpnI fragment of pAV1 was ligated
to pAV2 digested with EcoRV-KpnI (KpnI of MCS of
pUC18) resulting in pAV-CaHGT1 which, on sequence
analysis, revealed a complete ORF comprising 545 amino
acids (Fig. 1B). The protein has a predicted molecular
mass of 60.67 kDa.
3.2. Sequence analysis of the CaHGT1 gene
Substantial sequence similarity was observed between
the cloned ORF and the members of glucose transporter
families of S. cerevisiae and Schizosaccharomyces pombe
[17,18]. The greatest similarity (51% identity) was observed
with HGT1, a high-a⁄nity glucose transporter of K. lactis
and hence the gene was designated CaHGT1. Hydropho-
bicity values determined at each residue by the method of
Eisenberg et al. using a window size of 15 residues [20]
showed the presence of 12 putative transmembrane (TM)
domains (Fig. 1C), a characteristic feature of the major
facilitator superfamily [21]. The alignment of amino acid
sequences of CaHGT1 (accession number Y16834) of C.
albicans with HGT1 (accession number U22525) of K. lac-
tis ; GHT1 (accession number X91218), GHT2 (accession
number AF017180) and GHT3 (accession number
AF051139) of S. pombe ; HXT1 (accession number
U00060) and HXT2 (accession number M33270) of S.
cerevisiae; GLUT1 (accession number S80434), GLUT2
(accession number L09674) and GLUT3 (accession num-
ber M20681) of Homo sapiens and SNF3 (accession num-
ber J03246) glucose sensor of S. cerevisiae [24], generated
using the CLUSTALW program (data not shown), re-
vealed a conserved signature (IDKVGRRPLLIGG) typi-
cal of sugar facilitators (MFS) [21]. The sequence similar-
ities among glucose transporters from yeast to human
justify a close relationship of CaHgt1p with the high-af-
¢nity glucose transporter Hgt1p of K. lactis. In a dendro-
gram (data not shown), CaHGT1 and HGT1 of K. lactis
form a distinct family of transporters which is less related
to the group of Hxtp of S. cerevisiae than to the cluster of
hexose transporters represented by Ghtp members of
S. pombe [23,24]
Nucleotide sequence analysis revealed the presence of
TATA-like motif at position 3107 with correlated CAP
signal, as assessed using the EUKPROM algorithm (PC
Gene, IntelliGenetics). The 5P upstream region of the ini-
tiation codon was found to be A+T-rich and harbouring a
number of regulatory elements. Most striking was the
presence of a putative progesterone/glucocorticoid re-
sponse element (PRE, GRE: AGAACA) at 3718 and a
putative estrogen response element (ERE: TGACAT) at
3453 with respect to ATG [22]. A putative pheromone
response element (PhRE: TGTAAAAA) was also found
at position 3991. The putative elements of PDR1 and
PDR3, which are present in HXT9 and HXT11 of S. cere-
visiae, were absent in CaHGT1 promoter.
3.3. CaHGT1 could complement the glucose transport
defect when expressed in S. cerevisiae
In order to check the functionality of the cloned puta-
tive glucose transporter, the glucose uptake-de¢cient strain
RE700A of S. cerevisiae, which is devoid of HXT1, 2, 3, 4,
5, 6 and 7 [13], was used for heterologous expression of
the CaHGT1 gene. The CaHGT1 ORF was placed under
the copper-inducible promoter (CUP1) in the expression
vector pYEX-BX with URA3 as the auxotrophic selectable
marker. The expression construct pYEX-CaHGT1 was
used to transform RE700A, yielding several colonies on
medium containing 2% maltose without uracil. These col-
onies were then tested for growth on glucose. The trans-
formants showed growth on glucose while RE700A and its
transformant containing empty vector pYEX-BX did not
show any growth on glucose (Fig. 2A). In order to con¢rm
that the phenotype was plasmid-based, one of the trans-
formants, AVY701, was grown under non-selective condi-
tions (2% maltose+uracil) for several generations and then
plated onto glucose-containing medium without uracil
where several colonies failed to grow (data not shown).
This con¢rmed that the growth of AVY701 on glucose
was conferred by the plasmid pYEX-CaHGT1.
The glucose transport and speci¢city were determined
enzymatically by following its consumption from the me-
dium (Fig. 2B). A steady consumption of glucose was
demonstrated by the transformant AVY701 which was
comparable even in the presence of a threefold excess of
D-galactose. This con¢rmed that the observed D-glucose
consumption was mediated by a speci¢c heterologously
expressed C. albicans glucose transporter, CaHgt1p. The
apparent KT value in the range of 1 mM was obtained
from a Lineweaver-Burk plot (data not shown). Based
on KT values of other hexose transporters [25,26], it would
mean that the CaHGT1 gene product encodes a high-af-
¢nity glucose transporter.
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3.4. CaHGT1 expression can be induced by progesterone
and drugs
Northern blot analysis revealed that C. albicans cells
incubated with 1 mM progesterone for 15 min exhibited
enhanced expression of CaHGT1 (Fig. 3A, lane 3) as com-
pared to the control (lane 1). L-Oestradiol, on the other
hand, did not a¡ect the expression of CaHGT1 (lane 2).
Interestingly, when C. albicans cells were preincubated
with di¡erent drugs, viz. benomyl, chloramphenicol, cyclo-
heximide, miconazole and 4-nitroquinoline-N-oxide, the
expression of CaHGT1 was enhanced upon incubation
with only cycloheximide, benomyl and chloramphenicol.
In comparison, the increase in expression was maximal
with cycloheximide (Fig. 3B).
Earlier studies have suggested that the MFS protein and
facilitative glucose transporter (Glut1p) of mammalian
cells [12] could be involved in the development of drug
resistance. Furthermore, HXT9 and HXT11 are regulated
by transcription factors PDR1 and PDR3 which regulate
the ABC transporters required for drug resistance in yeast.
The induced expression of CaHGT1 by drugs would sug-
gest commonality among these MFS proteins. Whether
CaHgt1p and several other putative glucose transporters
of C. albicans (http://www.alces.med.umn.edu) are also
regulated by ABC regulators remains to be established.
It is tempting to speculate that the study of sugar trans-
porter genes and their regulation would lead to a better
understanding of the regulation of drug susceptibilities of
C. albicans.
Mammalian steroid hormones from the microenviron-
ment have been found to a¡ect the growth and morpho-
genesis of the invading C. albicans [27]. In addition, oes-
trogen binding proteins (EBP) have been identi¢ed in C.
albicans [28] which binds oestrogen with high a⁄nity,
stimulating the transition from yeast to the mycelial
form [27]. The interaction of some of the azoles, such as
ketoconazole, with the corticosteroid receptor and binding
protein has also been suggested. We have earlier reported
that human steroid hormones can up-regulate the expres-
sion of an ABC transporter, CDR1 (Candida drug resist-
ance) [5,14]. In this study we further show that progester-
one can also transcriptionally activate the expression of
the MFS transporter CaHGT1. The mechanism underlying
steroid-mediated gene regulation in yeast is not clear. It is
worth pointing out that steroid response elements do exist
in Candida genes (http://www.alces.med.umn.edu), though
unlike their mammalian counterparts, they do not exist as
Fig. 2. Functional analysis of CaHGT1. A: Growth of AVY701. Comparison of growth of the transformant AVY701, RE700A and RE700A+vector-
(pYEX-BX) on 2% glucose without uracil. B: Consumption of D-glucose by AVY701, RE700A and RE700A+vector. (P) RE700A; (b) AVY701;
(F) RE700A+vector; (7) consumption of D-glucose by AVY701 in the presence of a threefold excess of D-galactose. The transformed strain AVY701
was grown in YNB medium containing 2% glucose without uracil ; RE700A containing empty vector was grown in YNB containing 2% maltose without
uracil ; and RE700A was grown in YNB containing 2% maltose with uracil. After harvesting, the cells were washed with YNB and transferred to fresh
YNB for 2 h. The enzymatic assay for D-glucose consumption was done as described by Bergmeyer [16].
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palindromic repeats but only as one half of one. This,
however, could suggest that Candida may harbour a
unique steroid receptor cascade which remains unidenti-
¢ed. This aspect of gene regulation, mediated by human
steroid hormones in C. albicans, is under investigation.
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